Luminex to Seek Slice of Newborn Screening Market This Year | GenomeWeb

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – Austin, Texas-based molecular diagnostics and multiplex instruments firm Luminex on Wednesday presented its plans to enter the newborn screening market over the next couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.